CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES and PRODUCT ADMINISTRATION INTERRUPTED

1,480 reports of this reaction

6.7% of all CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES reports

#1 most reported adverse reaction

Overview

PRODUCT ADMINISTRATION INTERRUPTED is the #1 most commonly reported adverse reaction for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, manufactured by Jazz Pharmaceuticals, Inc.. There are 1,480 FDA adverse event reports linking CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES to PRODUCT ADMINISTRATION INTERRUPTED. This represents approximately 6.7% of all 22,248 adverse event reports for this drug.

Patients taking CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES who experience product administration interrupted should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PRODUCT ADMINISTRATION INTERRUPTED1,480 of 22,248 reports

PRODUCT ADMINISTRATION INTERRUPTED is moderately reported among CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES users, representing a notable but not dominant share of adverse events.

Other Side Effects of CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES

In addition to product administration interrupted, the following adverse reactions have been reported for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES:

Other Drugs Associated with PRODUCT ADMINISTRATION INTERRUPTED

The following drugs have also been linked to product administration interrupted in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE

Frequently Asked Questions

Does CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES cause PRODUCT ADMINISTRATION INTERRUPTED?

PRODUCT ADMINISTRATION INTERRUPTED has been reported as an adverse event in 1,480 FDA reports for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PRODUCT ADMINISTRATION INTERRUPTED with CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES?

PRODUCT ADMINISTRATION INTERRUPTED accounts for approximately 6.7% of all adverse event reports for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, making it one of the most commonly reported side effect.

What should I do if I experience PRODUCT ADMINISTRATION INTERRUPTED while taking CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES?

If you experience product administration interrupted while taking CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES Full ProfileAll Drugs Causing PRODUCT ADMINISTRATION INTERRUPTEDJazz Pharmaceuticals, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.